Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$339K Buy
966
+38
+4% +$13.5K 0.05% 249
2025
Q4
$304K Buy
928
+42
+5% +$13.3K 0.06% 198
2025
Q3
$250K Sell
886
-62
-7% -$18K 0.05% 202
2025
Q2
$265K Sell
948
-119
-11% -$33.7K 0.06% 194
2025
Q1
$332K Sell
1,067
-253
-19% -$74.7K 0.09% 160
2024
Q4
$344K Sell
1,320
-221
-14% -$65.6K 0.1% 156
2024
Q3
$497K Buy
1,541
+275
+22% +$90K 0.19% 98
2024
Q2
$396K Buy
1,266
+506
+67% +$149K 0.2% 106
2024
Q1
$216K Sell
760
-413
-35% -$121K 0.2% 151
2023
Q4
$338K Buy
+1,173
New +$320K 0.38% 82

Other funds holding AMGN

Seeds Investor's AMGN Position: Q1 2026 in Review

Seeds Investor increased its Amgen (AMGN) stake by 4.1% in Q1 2026, buying an estimated $13.5K and bringing the position to 966 shares worth $339K. The position accounts for 0.05% of the portfolio, ranked #249.

Seeds Investor first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $497K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Seeds Investor held 966 shares of Amgen worth $339K as of Q1 2026.
  • Seeds Investor bought 38 Amgen shares in Q1 2026, an estimated $13.5K.
  • Amgen made up 0.05% of Seeds Investor's portfolio in Q1 2026, its #249 holding.
  • Seeds Investor first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Seeds Investor's Amgen position peaked at $497K in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Seeds Investor's 13F filing for Q1 2026, filed 11 May 2026.